TUBERCULOSIS IN CHILDREN

Tuberculosis (TB) in children is a neglected aspect of the TB epidemic despite it constituting 20% or more of all TB cases in many countries with high TB incidence. Childhood TB is a direct consequence of adult TB but remains overshadowed by adult TB because it is usually smear-negative. Infants and...

Full description

Bibliographic Details
Main Author: Susanna Esposito
Format: Article
Language:English
Published: PAGEPress Publications 2013-11-01
Series:Mediterranean Journal of Hematology and Infectious Diseases
Subjects:
Online Access:http://www.mjhid.org/index.php/mjhid/article/view/425
id doaj-59a2896aa6d84289b7789f94a62ad5d5
record_format Article
spelling doaj-59a2896aa6d84289b7789f94a62ad5d52020-11-25T00:03:21ZengPAGEPress PublicationsMediterranean Journal of Hematology and Infectious Diseases2035-30062013-11-0151e2013064e201306410.4084/mjhid.2013.064317TUBERCULOSIS IN CHILDRENSusanna Esposito0Pediatric Clinic 1, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, ItalyTuberculosis (TB) in children is a neglected aspect of the TB epidemic despite it constituting 20% or more of all TB cases in many countries with high TB incidence. Childhood TB is a direct consequence of adult TB but remains overshadowed by adult TB because it is usually smear-negative. Infants and young children are more likely to develop life-threatening forms of TB than older children and adults due to their immature immune systems. Therefore, prompt diagnoses are extremely important although difficult since clinical and radiological signs of TB can be non-specific and variable in children. Despite undeniable advances in identifying definite, probable, or possible TB markers, pediatricians still face many problems when diagnosing TB diagnosis. Moreover, curing TB can be difficult when treatment is delayed and when multi-drug resistant (MDR) pathogens are the cause of the disease. In these cases, the prognosis in children is particularly poor because MDR-TB treatment and treatment duration remain unclear. New studies of diagnostic tests and optimal treatment in children are urgently needed with the final goal of developing an effective anti-TB vaccine.http://www.mjhid.org/index.php/mjhid/article/view/425extrapulmonary tuberculosisMycobacterium tuberculosismultidrug resistant Mycobacterium tuberculosispediatric tuberculosistuberculosis.
collection DOAJ
language English
format Article
sources DOAJ
author Susanna Esposito
spellingShingle Susanna Esposito
TUBERCULOSIS IN CHILDREN
Mediterranean Journal of Hematology and Infectious Diseases
extrapulmonary tuberculosis
Mycobacterium tuberculosis
multidrug resistant Mycobacterium tuberculosis
pediatric tuberculosis
tuberculosis.
author_facet Susanna Esposito
author_sort Susanna Esposito
title TUBERCULOSIS IN CHILDREN
title_short TUBERCULOSIS IN CHILDREN
title_full TUBERCULOSIS IN CHILDREN
title_fullStr TUBERCULOSIS IN CHILDREN
title_full_unstemmed TUBERCULOSIS IN CHILDREN
title_sort tuberculosis in children
publisher PAGEPress Publications
series Mediterranean Journal of Hematology and Infectious Diseases
issn 2035-3006
publishDate 2013-11-01
description Tuberculosis (TB) in children is a neglected aspect of the TB epidemic despite it constituting 20% or more of all TB cases in many countries with high TB incidence. Childhood TB is a direct consequence of adult TB but remains overshadowed by adult TB because it is usually smear-negative. Infants and young children are more likely to develop life-threatening forms of TB than older children and adults due to their immature immune systems. Therefore, prompt diagnoses are extremely important although difficult since clinical and radiological signs of TB can be non-specific and variable in children. Despite undeniable advances in identifying definite, probable, or possible TB markers, pediatricians still face many problems when diagnosing TB diagnosis. Moreover, curing TB can be difficult when treatment is delayed and when multi-drug resistant (MDR) pathogens are the cause of the disease. In these cases, the prognosis in children is particularly poor because MDR-TB treatment and treatment duration remain unclear. New studies of diagnostic tests and optimal treatment in children are urgently needed with the final goal of developing an effective anti-TB vaccine.
topic extrapulmonary tuberculosis
Mycobacterium tuberculosis
multidrug resistant Mycobacterium tuberculosis
pediatric tuberculosis
tuberculosis.
url http://www.mjhid.org/index.php/mjhid/article/view/425
work_keys_str_mv AT susannaesposito tuberculosisinchildren
_version_ 1725434545522606080